Jump to content

AJ Kanwar

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 22:59, 23 July 2022 (Add: date. | Use this bot. Report bugs. | Suggested by Smasongarrison | Linked from User:Smasongarrison/sandbox/1 | #UCB_webform_linked 3038/3850). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Dr AJ Kanwar (born 29 June 1948) is an Indian Dermatologist. He has been Senior Professor and Head, Department of Dermatology, Venereology & Leprology, PGI Chandigarh[1] and currently practices in his hometown, New Delhi, India. Dr AJ Kanwar is the son of Late Shri Inder Singh and Smt Shanti Devi and was born on 29 June 1948. He attended school in New Delhi and graduated from the prestigious institute AIIMS, New Delhi in MBBS (Dermatology) in 1969. He continued in AIIMS, New Delhi to obtain his post graduate degree (M.D.) in Dermatology and Venereology in 1975. After his senior residency in AIIMS, Dr Kanwar went on a foreign assignment in Benghazi, Libya. He also served a year in St John's Institute of Dermatology, London during a Commonwealth Medical Fellowship. He received a special training in Pediatric Dermatology during this year. To his credit are also time in National Institute of Health, Washington USA in 2006 for a Fellowship in AIDS, and a month in Kurume, Japan in 2010 for special training in Pemphigus. Dr Kanwar's foreign assignment in Libya, ended in 1987 when he returned to join PGI Chandigarh.

In 2020, based on an independent study done by scientists at Stanford University, he was ranked amongst the top 2% Indian Scientists.[2][3][4] He was awarded Dr B.C. Roy National award, one of the highest recognition given in the field of medicine, by the President of India, on 1 July at the Rastrapati Bhawan.[5] The Indian Medical Council gave him the Lala Ram Chand Kandhari Award to him, in 2010 for his outstanding work in Vitiligo.[6][7][8] He was also the first in India to report efficacy of Rituximab for treatment of Pemphigus[9][10] He was selected as a fellow of National Academy of Medical Sciences (FAMS) in 2008 and as a Fellow of Royal College of Physicians (FRCP) London in 2011.

He has more than 592 publications to his credit, in national and international Textbooks and Journals. In 2011, he was credited as first in India to report efficacy and safety of Rituximab for treatment of Pemphigus.[11] He is co-author of Textbook of Surgical Management of Vitiligo published by Blackwell[12][13]

Awards and recognition

  • Ranked top 2% Indian Scientist in the world based on a 2020 Independent study done by Stanford University scientists.[2]
  • Awarded Dr. B. C. Roy Award (2010) for Eminent Medical Teacher in the field of Dermatology[5][14]
  • Awarded with Dr RV Rajam Oration (2013–2014) Annual Meeting of National Academy of Medical Science[15]
  • Received ICMR Lala Ram Chand Kandhari Award (2010) for his work on therapy and other aspects of vitiligo[6][7][8]

References

  1. ^ "Five HoDs to say good bye to PGI this year". 2 January 2014. Retrieved 3 July 2016.
  2. ^ a b "World Rankings: 10 PGIMER doctors rank among top scientists". Hindustan Times. 2 November 2020. Retrieved 15 March 2022.{{cite web}}: CS1 maint: url-status (link)
  3. ^ "world ranking of scientist (2%).xlsx". Google Docs. Retrieved 2 November 2020.
  4. ^ "World Ranking of top 2% Indian scientist - Google Drive". docs.google.com. Retrieved 2 November 2020.
  5. ^ a b IANS (July 2016). "President confers B.C. Roy awards". Business Standard India. Retrieved 3 July 2016.
  6. ^ a b "ICMR honours 8 PGI medicos for research". The Times of India. Retrieved 3 July 2016.
  7. ^ a b "The Tribune, Chandigarh, India – Nation". www.tribuneindia.com. Retrieved 3 July 2016.
  8. ^ a b "Ghulam Nabi Azad presents ICMR Awards to 51 scientists | India Medical Times". Retrieved 3 July 2016.
  9. ^ Kanwar, A.j.; Tsuruta, D.; Vinay, K.; Koga, H.; Ishii, N.; Dainichi, T.; Hashimoto, T. (1 January 2013). "Efficacy and safety of rituximab treatment in Indian pemphigus patients". Journal of the European Academy of Dermatology and Venereology. 27 (1): e17–e23. doi:10.1111/j.1468-3083.2011.04391.x. ISSN 1468-3083. PMID 22176540. S2CID 11881103.
  10. ^ Kanwar, Amrinder J.; Sawatkar, Gitesh U.; Vinay, Keshavamurthy; Hashimoto, Takashi (1 October 2012). "Childhood pemphigus vulgaris successfully treated with rituximab". Indian Journal of Dermatology, Venereology and Leprology. 78 (5): 632–634. doi:10.4103/0378-6323.100587. ISSN 0973-3922. PMID 22960821.
  11. ^ Kanwar, A. J.; Tsuruta, D.; Vinay, K.; Koga, H.; Ishii, N.; Dainichi, T.; Hashimoto, T. (1 January 2013). "Efficacy and safety of rituximab treatment in Indian pemphigus patients". Journal of the European Academy of Dermatology and Venereology. 27 (1): e17–23. doi:10.1111/j.1468-3083.2011.04391.x. ISSN 1468-3083. PMID 22176540. S2CID 11881103.
  12. ^ "Blackwell Book Co-Authored by Dr AJ Kanwar".
  13. ^ Dr K K Aggarwal (19 July 2016), Dr A J Kanwar on receiving Dr BC Roy National Award, retrieved 29 July 2016
  14. ^ "25 Doctors conferred Dr BC Roy Award by the President on Doctors Day – Medical Dialogues". 1 July 2016. Retrieved 3 July 2016.
  15. ^ "Dr RV Rajam Oration" (PDF).


Flag of IndiaBiography icon

This Indian medicine-related biographical article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=AJ_Kanwar&oldid=1100040212"